Introduction
The c-myc protooncogene encodes a basic helix ± loop ± helix (bHLH) transcription factor which, through association with its partner protein Max, binds to a speci®c E-box hexamer located in control regions of various target genes (for review see Facchini and Penn, 1998; LuÈ scher and Larsson, 1999) . Regulated expression of c-myc and its target genes is required for cell cycle progression and cellular proliferation (Mateyak et al., 1999 and references therein) . c-myc is an essential gene as revealed by the lethality of homozygous knock-out embryos around midgestation (Davis et al., 1993) . This early embryonic lethality precluded further studies on the role of c-myc in the concerted proliferation and cell dierentiation programs underlying development. We decided to investigate its role using a dierent approach, based on observation that the control of c-myc mRNA stability plays an essential role in the regulation of cmyc gene expression. Several cis-acting sequences have been shown to participate in this control. Most studies have focused on the 3' UTR because it includes an AUrich element (ARE), ®rst described in the 3' UTR of cfos mRNA (Treisman, 1985) and subsequently in many other labile cytokine/lymphokine and protooncogene mRNAs (Caput et al., 1986) and review in (Chen and Shyu, 1995) . c-myc ARE was shown to be actively involved in the regulated expression of c-myc in cultured cells (Alberta et al., 1994; Brewer and Ross, 1989; Cole and Mango, 1990; Herrick and Ross, 1994) and review in (Chen and Shyu, 1995) . However, other non-ARE elements exist in the coding regions of c-myc mRNA which play an important role in the control of mRNA stability, ex vivo (Yeilding and Lee, 1997) and in vivo (Lavenu et al., 1995) .
How the dierent c-myc instability determinants function and whether they act as partly redundant or independent elements in a particular environmental or dierentiated cellular context remain important open questions. In the present study, we have tested the role of the 3' UTR in vivo in developing mice. To do so, we created various modi®ed c-myc alleles using homologous recombination in embryonic stem (ES) cells and the Cre-loxP system. Since c-myc 3' UTR contains several runs of Us and AREs potentially capable of leading to destabilization through interaction with numerous trans-acting factors (Wilson and Brewer, 1999) , we deleted the entire 3' UTR, including the two polyadenylation sites, and replaced it by the SV40 3' UTR, including a single polyadenylation site. This strategy of targeting mutations directly at the c-myc locus allowed us to observe the consequences both in totipotent ES cells and throughout development of the derived transgenic mice. In the various situations examined, including liver dierentiation and regeneration, we did not observe a dierence in the level of expression of c-myc transcripts, irrespective of whether or not they contained the c-myc 3' UTR. Moreover, mice homozygous for 3' UTR-deleted alleles were healthy and fertile and showed a normal development. We further took advantage of the fact that we had inserted a¯oxed polII neomycine cassette immediately upstream of the 3' UTR to test the activity of the cmyc 3' UTR independently of the presence of c-myc coding sequences. All together, our results strongly suggest that this untranslated region, alone or in association with the coding region, does not signi®-cantly contribute to the regulation of c-myc mRNA expression in vivo.
Results

Generation of modified c-myc alleles
To study the consequences of deleting the ARE from the resident c-myc gene on mRNA turnover rate, we generated recombinant ES cells by using the Myc* neo3'SV targeting vector (Figure 1b ) which contained c-myc genomic DNA altered as follows: (1) a 159-nt-long human c-myc sequence encoding the carboxy terminal part of Myc protein was inserted in place of the corresponding murine sequences (see Materials and methods); (2) a neomycin-resistance cassette, with an RNA polymerase II (polII) promoter but without a polyadenylation sequence, was inserted immediately downstream of the c-myc stop codon. This cassette was oxed, so that transient transfection of targeted ES cells with a Cre-expressing vector resulted in its deletion ( Figure 1d) ; (3) the c-myc 3' UTR, including runs of Us, AREs and the two pA sites (see Figure 1a) , was deleted and replaced by late SV40 3' UTR, including a pA site. In parallel, we derived a control allele which retains the c-myc 3' UTR but carries all the other modi®cations introduced into the Myc* ). G418-resistant ES clones were analysed by Southern blot to identify homologous recombinants at the c-myc locus (see Materials and methods). Targeted clones containing either the myc* neo3'myc (clone neo3'myc) or the myc* neo3'SV allele (clone neo3'SV) were subsequently transiently transfected with a vector driving the expression of Cre recombinase in order to delete the neo cassette. G418-sensitive clones were screened by PCR and Southern blot analysis (see Materials and
Figure 1 Strategy used to generate the dierent modi®ed c-myc alleles. (a) WT c-myc gene with the three exons (grey boxes) and the 3' UTR (black box) which has been enlarged to show the location of the two AREs (striped boxes), each one including an AUUUA motif (star), and the two pA sites (pA1 and pA2). Recombination with the myc* neo3'SV targeting vector (b) gives rise to the myc* neo3'SV allele (c), in which the polIIneo cassette¯anked by lox P sites (arrow) is inserted immediately 3' of the c-myc stop codon. In vitro or in vivo deletion of the neo cassette after Cre recombinase (Cre) action results in the myc* 3'SV allele (d). Similarly, recombination with myc* neo3'myc targeting vector (not shown, see Materials and methods) creates the myc* neo3'myc allele and subsequently, after excision of the cassette, the myc* 3'myc control allele (e). The asterisk in the dierent alleles obtained symbolized the fragment of human genomic c-myc introduced in place of the corresponding murine c-myc sequence Absence of the c-myc 3' UTR does not modify c-myc mRNA expression in ES cells
To analyse the contribution of ARE to the level of expression of c-myc mRNA, we compared expression of the mutant gene (mg) in the D3'myc and D3'SV ES clones which are heterozygous for the modi®ed allele. First, an S1 nuclease analysis was performed using the Hu probe depicted in Figure 2a and the b2 microglobulin (b2m) probe, used to calibrate the amounts of RNAs. No dierence in the level of expression of the modi®ed c-myc mRNAs could be observed between the two clones ( Figure 2b ). These results were con®rmed by real-time quantitative RT ± PCR analysis using two dierent couples of primers, MYC TOU 1 ± 3 and MYC TOU 1 ± 4 which speci®cally hybridize to the human c-myc genomic sequence contained in the c-myc modi®ed allele (see Materials and methods and Table  1 ). Then, we directly compared wild-type and Myc* 3'SV mRNA expression in the D3'SV clone by S1 nuclease analysis using the Hu and Mu probes (diagram Figure  2a) which were of comparable length and similar speci®c activity. We used the property of transient responsiveness of the c-myc promoter to serum (Gibson et al., 1986 ) and compared the level of induction of wild-type and mutant c-myc alleles within the same cell sample. Cells of D3'SV clone were serumstarved and then restimulated with medium containing 15% FCS to transiently activate c-myc gene transcription. The cells were harvested after 10 min (0 h), 1 h, 3 h, and 10 h and the RNAs were extracted and hybridized simultaneously to Hu or Mu and b2 m probes. As shown in Figure 2c ,d, the kinetics of accumulation of endogenous (wt) and modi®ed (mg) cmyc transcripts were similar after serum induction. Identical results were obtained in the D3'myc clone where the levels of wt and c-myc modi®ed transcripts were very similar in normally grown cells or after serum addition (data not shown). All together, these results indicate that neither the addition of human cmyc sequences and loxP site nor the deletion of c-myc 3' UTR and its replacement by SV40 3' UTR noticeably modify c-myc mRNA expression in ES cells, even in conditions of serum-stimulation.
Expression of 3' UTR-deleted c-myc transcripts is not altered during liver differentiation and regeneration or in quiescent adult organs
In a subsequent series of experiments, we decided to directly address the role of c-myc 3' UTR in the control of c-myc mRNA expression in vivo. To that end, mice carrying the various 3' modi®ed c-myc alleles were generated via the creation of chimeric mice (see Materials and methods). The chimeras were bred with wild-type mice to establish genetically altered transgenic lines. The genotype of the dierent mice was established by PCR ( Figure 3 and Materials and methods). We could then compare the levels of modi®ed and wild-type c-myc transcripts both throughout normal development and in various situations in which the control of mRNA stability had previously been shown to play a major role in the regulation of cmyc expression, in particular quiescent adult organs, the liver after partial hepatectomy and during dierentiation.
To test whether expression of the deleted allele was altered in quiescent adult organs, we performed an S1 nuclease protection assay using various +/Myc* 3'SV (Table 1) . By contrast, wt and mutant cmyc transcripts (myc* 3'myc or myc* 3'SV ) were barely detectable in liver or kidney ( Figure 4b and data not shown). All together, these data show that neither the deletion of the 3' UTR nor the other modi®cations included in the dierent modi®ed alleles signi®cantly alter the level of expression of c-myc mRNA in quiescent adult organs.
To study the possible consequence of 3' UTR deletion on the kinetics of c-myc upregulation during liver regeneration (Morello et al., 1990b; Sobczak et al., 1989) , the S1 nuclease protection assay was performed on RNAs extracted from +/Myc* 3'SV heterozygous mice (males or females) sacri®ced 1 h, 2 h and 4 h after partial hepatectomy; sham-operated mice were used as a control (0 h). As shown in Figure 5a (and quanti®ed in 5b), expression of modi®ed and wt c-myc mRNA remained parallel during the early steps of liver regeneration with a peak at 1 ± 2 h and a subsequent rapid decrease, kinetics comparable to those observed in control mice (Morello et al., 1990a) . The c-myc down-regulation observed during liver dierentiation was also analysed by S1 nuclease analysis of RNAs extracted from a pool of 2 ± 4 livers dissected from 13.5 and 16.5 dayold heterozygous +/Myc* 3'SV embryos (E13.5 and E16.5), neonates (b), 7-day-old (P7) or adult mice (ad), using the Mu probe described in Figure 4a . As shown in Figure 5c (and quanti®ed in 5d), the kinetics of c-myc mRNA decrease during liver dierentiation were very similar for wt and altered transcripts, with an expression high in the fetal livers and disappearing around birth. However, we noticed that the wt/mg ratio is reversed at birth, suggesting that one of the modi®cations borne by the transgene might slow down c-myc mRNA decay at this developmental stage. Taken together, with this possible exception, our data indicate that, in all situations analysed, there is no signi®cant dierence between the level of accumulation of c-myc transcripts synthesized from the c-myc 3' UTR-deleted allele (Myc* 3'SV ), the modi®ed control (Myc* 3'Myc ) and the wt c-myc allele.
The c-myc 3' UTR does not modify the steady-state level of neo trancripts
The fact that we did not observe changes in expression of mRNA synthesized from the deleted allele did not exclude the possibility that this deletion might be counterbalanced by redundant elements present in the c-myc coding region. To study the possible destabilizing role of c-myc 3'UTR per se, we took advantage of the fact that we have inserted the polII neo cassette without a polyadenylation site upstream of the 3' UTR in Myc* neo3'myc and Myc* neo3'SV constructs to compare the level of expression of polII/neo transcripts between Myc* neo3'Myc or Myc* neo3'SV tissues. S1 nuclease analysis was performed using a probe designed to distinguish between the mycneo transcripts initiated at the c-myc promoters and the neo transcripts initiated at the polII Figure 3 PCR analysis of ospring obtained after intercrosses between +/Myc* 3'myc (=+/*myc) or +/Myc* 3'SV (=+/*SV) heterozygous using the 126 and 199 primers whose localization is shown in Figure 1a . C-. negative control of PCR TBP  61  70  73  82  137  189  79  102  P0  40  50  59  66  137  188  99  127  Thymus  TBP  70  78  100  100  128  101  168  203  P0  140  159  100  100  86  136  120  145 The amount of mutated c-myc RNAs contained in RNA extracted from ES cells or spleen and thymus of adult mice of the indicated genotype was quanti®ed using a real time reverse transcription PCR-assay. For each sample, the PCR was performed using two dierent couples of myc primers MYC TOU 1-3 and MYC TOU 1-4 located in the human c-myc genomic sequence (see Materials and methods). The quanti®cation was performed relative to the amount of P0 and TBP mRNAs found in each sample, which have been chosen as internal references. The values are expressed relative to the amount of c-myc modi®ed transcripts found in the +/3'myc 73'SV thymus which was arbitrarily expressed as 100 (see Materials and methods). Nd: not done Oncogene Targeted c-myc 3' UTR modifications F Langa et al promoter, which do not contain c-myc coding sequences (see diagram Figure 6a ). The results obtained with RNAs extracted from either quiescent adult organs or embryonic tissues (head and trunk) at E12.5 and E14.5 (data not shown) showed no signi®cant dierence neither in the level of myc* neo3'Myc or myc* neo3'SV transcripts nor in the level of polIINeo 3'myc or polIINeo 3'SV transcripts at any developmental stages analysed (Figure 6b) . A similar conclusion was obtained from an analysis performed on neo3'myc and neo3'SV ES cell clones (data not shown). These data indicate that the level of accumulation of neo mRNA in ES cells, quiescent organs or in proliferating embryonic tissues is not in¯uenced by the origin of the 3' UTR -c-myc or SV40-.
Modification of the c-myc 3' UTR neither alters mouse development nor leads to tumorigenesis A change in c-myc mRNA turnover could result either in tumor formation in case of higher stability (review in Cole, 1986; Marcu et al., 1992) , or defects in the developmentally programmed proliferation/dierentiation processes in case of lower stability. +/Myc* 3'SV heterozygotes were therefore carefully analysed for the appearance of tumors or developmental defects and bred to homozygosity to increase the potential eect of the mutation. Mice homozygous for the 3' UTR deletion were obtained at weaning at the expected Mendelian frequency. Furthermore, they developed to maturity with no obvious abnormalities. When intercrossed, their ospring were viable and fertile. Analysis of c-myc mRNA expression performed by quantitative RT ± PCR and S1 nuclease analysis on RNA extracted from thymus or spleen indicated that their level was similar in Myc* 3'SV/3'SV and Myc* 3'Myc/3'Myc homozygous mice and was approximately twice the level found in the heterozygous mice (Figure 4b ,c, Table 1 and data not shown). We did not observe the formation of tumors in either heterozygous or homozygous mice, the oldest ones being more than 18 months-old at the time of writing. Similar conclusions could be drawn from the analysis of Myc* neo3'myc or +/Myc* neo3'SV mice which developed without any problem and expressed comparable levels of modi®ed c-myc transcripts in their lymphoid organs (Table 2) . These results indicate therefore that the deletion of c-myc 3' UTR or its lengthening due to insertion of the neo cassette does not alter fertility, reproductive eciency and viability of mice bearing the corresponding mutation.
Discussion
Regulation of c-myc expression at the level of mRNA stability has been documented in various situations, both in vitro and in vivo, under normal or pathological conditions (reviews in Aghib et al., 1990; Cole 1986; Cole and Mango, 1990; Herrick and Ross, 1994; Laird-Oringa, 1992; Marcu et al., 1992) . Numerous (+/*S) heterozygotes. The signals obtained after S1 nuclease analysis shown in b were quanti®ed using a phosphorimager. The histograms represent the values calculated as described in Materials and methods. The dierence between wt and mg values is due to the dierent lengths of the protected fragments (500/367 nt for wt and mg, respectively)
Targeted c-myc 3' UTR modifications F Langa et al studies have been undertaken to identify cis-acting sequences involved in dictating the rate of c-myc mRNA turnover (Brewer and Ross, 1989; Herrick and Ross, 1994; Morello et al., 1993; Yeilding et al., 1996) and review in Ross, 1995) as well as the trans-acting factors with which they interact (Doyle et al., 1998; Wilson and Brewer, 1999 ). An abundant literature concerns the AU-rich element (ARE) found in the 3' UTR of c-myc as well as in that of other protooncogenes or growth-related mRNAs (review in Chen and Shyu, 1995) . Although the mechanism underlying ARE function remains to be determined, it is generally accepted that this element interacts with AU-binding proteins (AUBP), such as the recently cloned AUF1 (Zhang et al., 1993) and HuR (Myer et al., 1997) . This interaction leads to an increase in the rate of deadenylation, which is the ®rst step in AREdirected mRNA degradation (review in Chen and Shyu, 1995) . The speci®c contribution of c-myc 3' UTR in the control of mRNA decay has been addressed previously in vitro (Brewer, 1998) , ex vivo, using cultured cells transfected with chimeric constructs in which various parts of the c-myc 3' UTR were linked to reporter genes (Bonnieu et al., 1990; Cole and Mango, 1990 ; Jones and Cole, 1987; Laird-Oringa et al., 1991) and in vivo using trangenic mice carrying chimeric genes containing or not the c-myc 3' UTR (Lavenu et al., 1995; Morello et al., 1993) . On the one hand, ex vivo studies gave con¯icting results regarding whether adding the c-myc 3' UTR to heterologous mRNAs does lead or not to their destabilization (Jones and Cole, 1987; Laird-Oringa et al., 1991) . On the other hand, in vivo experiments indicating that the 3' UTR is dispensable for the post-transcriptional control of cmyc expression (Morello et al., 1993) were limited to developmental stages where the regulatory sequences chosen to drive transgene expression were active. In the present study, we decided to circumvent this limitation and chose to alter c-myc 3' UTR using homologous recombination in ES cells. This strategy allowed us to both follow expression of the modi®ed allele in the embryonic stem cells and throughout development via the construction of chimeras and to speci®cally test for the function of the 3' UTR, since the genetic modi®cation introduced is limited to this region and thus does not alter c-myc transcriptional control. In particular, it allowed to test the role of the ARE when and wherever c-myc promoters are active, a goal which could not be reached by classical approaches using cells or transgenic mice expressing chimeric constructs. Since the c-myc 3' UTR contains two polyadenylation (pA) Oringa et al., 1989) , we deleted the complete 3' UTR and replaced it by the widely used SV 40 3' UTR. In parallel, we derived a control allele which retains the cmyc 3' UTR but carries all the other modi®cations introduced into the Myc* 3'SV allele: the replacement of the carboxy terminal part of the murine c-myc encoding sequence by the corresponding human cmyc fragment and the insertion of a loxP site, and its associated polylinker sequences, downstream of the stop codon.
In view of the literature concerning the role of AREs in mRNA decay (review in Ross, 1995) , deletion of cmyc AREs was expected to stabilize c-myc transcript. Surprisingly, we found that the levels of expression of Myc* 3'SV mRNA were not signi®cantly dierent from those of wild-type or control Myc* 3'myc mRNAs either in the pluripotent embryonic stem cells or in derived heterozygous transgenic animals. This was true in physiological or experimental situations, such as liver dierentiation, liver regeneration and quiescent adult organs, in which c-myc expression has been shown to be controlled principally at the level of RNA stability. Our experiments comparing expression of polII neo mRNAs ending within c-myc or SV40 3' UTR sequences also showed that adding the c-myc 3' UTR to heterologous mRNAs does not lead to their destabilization in embryos or adult tissues. Finally, the fact that we could derive healthy and fertile heterozygous and homozygous mice corresponding to each of the four dierent modi®ed c-myc alleles, including or excluding the neo cassette located upstream of the c-myc or SV40 3' UTR, indicates that neither the deletion of the 3' UTR nor its lengthening due to insertion of loxP site or neo cassette, has a detrimental eect on development or favors tumorigenesis.
Interestingly, Kontoyiannis et al. (1999) using a similar strategy have recently shown that the regulation of TNF biosynthesis was impaired by removal of TNF ARE. The absence of the ARE region resulted in increased steady-state TNF mRNA levels and homozygous TNF DARE/DARE mice displayed early severe pathological manifestations and a reduced life span. Taken at their face value, these observations are at variance with the results presented in our study. However, it should be pointed out that, although TNF and c-myc 3' UTR both contain ARE, these AREs dier in their number of (A)AUUUA(AU) motif and organization: this motif is present only once in each c-myc ARE whereas it is repeated six times at a stretch in TNF ARE. The sequence conservation between c-myc ARE and the instability determinants found in other short-lived mRNAs, such as c-fos, GM-CSF or TNF, has been taken as supporting the hypothesis of a role for this element in mRNA degradation. Since our present results show that c-myc ARE does not in itself possess a destabilizing in¯uence, we suggest that the control of c- neo allele where the polIIneo cassette has been introduced in front of the 3' UTR (either c-myc (black box) or SV40 (grey squares). The readthrough myc/neo transcripts initiated at the c-myc promoter and the polIIneo transcripts initiated at the polII promoter protect the polIIneo probe from S1 nuclease digestion giving signals at 421 nt and % 290 nt, respectively. (b) Twenty mg of RNA extracted from (i) adult organs (sp: spleen; th: thymus; li: liver; ki: kidney) of Myc* neo3'myc (lanes 1 to 4) or Myc* neo3'SV (lanes 5 to 8) homozygotes and (ii) tissues (head, he and trunk, tr) of +/ Myc* neo3'myc (lanes 10, 11) or +/Myc* neo3'SV (lanes 12, 13) embryos were hybridized with the polIIneo and û2 m probes and an S1 nuclease analysis was performed. The speci®city of the probe is demonstrated by the absence of signals when RNA extracted from the spleen of Myc* 3'SV /Myc* 3'SV homozygotes (D/ D, lane 9) is used. Although the polII promoter is far less ecient than the c-myc promoters, the intensities of the polIIneo signals are not signi®cantly dierent between Myc* neo3'myc or Myc* neo3'SV tissues Table 2 mycneo3'myc/ mycneo3'SV/ Genotype tissue/cell +/mycneo3'myc +/mycneo3'SV mycneo3'myc mycneo3'SV Myc primers 1 ± 3 1 ± 4 1 ± 3 1 ± 4 1 ± 3 1 ± 4 1 ± 3 1 ± 4   Spleen  TBP  123  113  100  92  252  223  204  225  P0  45  80  92  85  241  213  139  153  Thymus  TBP  80  75  97  77  201  190  119  138  P0  112  104  119  99  255  242  140  163 See legend to Table 1 Targeted c-myc 3' UTR modifications F Langa et al myc RNA half-life might be ensured by the determinants located within the coding region. This hypothesis is supported by the studies highlightning the role of exon 2 and/or exon 3 in the control of c-myc mRNA stability ex vivo (Bernstein et al., 1992; Herrick and Ross, 1994; Yeilding and Lee, 1997; Yeilding et al., 1996) or in vivo (Lavenu et al., 1995; Pistoi et al., 1996) .
Materials and methods
Targeting vectors
Two targeting vectors, Myc* neo3'myc (see Figure 1b) and Myc* neo3'SV were derived from the targeting construct used to create a null c-myc mutation ( (Davis et al., 1993) ; gift of A Bradley). They contained respectively 11.5 and 9.3 kb of the mouse genomic sequence extending from the NotI site in exon 1 or the SacII site in exon 2 to an XbaI site 3' the coding region. To distinguish the modi®ed alleles from the wild-type allele, a fragment of human genomic c-myc gene was introduced in place of the corresponding murine c-myc sequence in both vectors (symbolized by an asterisk in the text and ®gures). Brie¯y, the human sequence encoding the last 77 amino acids was ampli®ed using the following two primers: 5'-GAGCGCCAGAGGAACG-3' and 5'-CTCCTC-GAGTGAATTCAGTTTATGCACCAGAGTTCCG-3'. The second contains a XhoI and an EcoRI site in its 5' part. The PCR-ampli®ed fragment was then digested with StyI and XhoI and the resulting 159-bp fragment introduced into the murine c-myc sequence in place of the 168-bp-long StyI-XhoI fragment. This exchange introduced a total of 19 mutations, seven leading to ®ve modi®ed codons.
A 1.7-kb EcoRI-EcoRI neo cassette was constructed from p21oxNeo plasmid (courtesy of S Tajbakhsh, Pasteur Institute); it contained neomycin coding sequences under the control of the RNA polymerase II promoter but does not include the HPRTpA site. The cassette,¯oxed by two loxP sites, was recovered after subcloning into the pBS64 plasmid (Courtesy of Sauer, Sauer and Henderson, 1990) . This cassette was inserted downstream of the c-myc STOP codon (see Figure  1b ,c) using the EcoRI site introduced 5' to the XhoI site.
In the Myc* neo3'SV vector, the c-myc 3' UTR was deleted and replaced by that of SV40 virus. For this purpose, the EcoRI(XhoI/)-MunI 440-bp fragment, including runs of Us, two AREs, two AUUUA motifs and the 2 pA sites (see Figure 1a ), was exchanged with an EcoRI-EcoRI fragment containing the 250-bp SV40 BamHI-BclI fragment from late 3' UTR including a pA site.
ES cells
Exponentially growing CK35 ES cells (Kress et al., 1998) derived from a 129/Sv embryo, were trypsinized and resuspended at a concentration of 16.10 6 cells per 0.8 ml of PBS and electroporated with 20 mg of NotI-linearized Myc* neo3'myc vector or SacII-XbaI Myc* neo3'SV DNA fragment at 220 V, 960 mF, using a Bio-Rad Gene Pulser. Cells were plated on a monolayer of G418-resistant embryonic ®broblasts. Selection with G418 (Gibco) (300 mg/ml; added 48 h after electroporation) was maintained for 10 days. In the case of Myc* neo3'SV targeting vector, which contained the HSV-TK type I gene inserted in orientation opposite to c-myc, Gancyclovir (Syntex Research) (2 mM) was added 72 h after electroporation. Resistant colonies were picked into individual wells of 24-well feeder plates under selection. After 4 ± 6 days, clones were frozen and expanded in parallel for DNA isolation.
For FCS pulse-chase, ES cells, exponentially grown in ES cell medium supplemented with 15% FCS, were growth arrested by 24 h of culture in DMEM containing 0.5% FCS. The medium was then replaced by ES cell medium containing 15% FCS and the cells were harvested 10 min, 1 h, 3 h or 10 h later for RNA analysis.
The neomycin cassette was eliminated by transient expression of the Cre recombinase encoded by the POG 231 plasmid (gift of P O'Gormam, Salk Institute, La Jolla). Recombinant ES cells were electroporated with 20 mg of supercoiled plasmid. Individual clones were picked and seeded into duplicate 24-well feeder plates containing or lacking G418. The myc* 3'myc or the myc* 3'SV allele recovered after deletion of the neo cassette contained, in addition to the human Myc sequences (*), an insertion of 93 bp, including a loxP site and dierent cloning sites used to create the¯oxed cassette (see Figure 1d ,e). In the case of ES cells targeted with the Myc* neo3'SV vector, the neo cassette was also removed in vivo by crossing directly a chimeric male (see below) with a transgenic female expressing the cre recombinase during oogenesis (Lallemand et al., 1998) .
Chimeric mice and transgenic lines
Chimeras were generated from injection of 5 ± 8 genetically modi®ed ES cells into C57Bl/6J blastocysts as described previously (Bradley, 1987) . To derive transgenic lines, +/ Myc* neo3'SV and +/Myc* neo3'myc chimeric males were crossed with F1(C57Bl/6JxDBA2) or Cre transgenic females (with a mixed C57Bl/6J, MF1, Ba1B/c genetic background (Lallemand et al., 1998)); +/Myc* 3'neo 3'SV chimeric males were also crossed with 129/Sv females to derive transgenic mice bearing the Myc* 3'neo3'SV allele in a pure 129/Sv background.
Southern blot analysis and PCR screening of recombinant clones and transgenic mice
Genomic DNA was isolated from individual ES clones and tested by Southern analysis, using as probes a 1.9-kb SacIIXhoI or a 1.7-kb XhoI-KpnI fragment which reveals, after EcoRI restriction, sequences located 5' and 3' to the neo cassette, respectively. The targeted clones were expanded and analysed with a series of dierent restriction enzymes to con®rm the targeting. The strategy of PCR analysis performed to identify the mice heterozygous or homozygous for one particular mutated allele after Cre recombinase action is depicted in Figures 1a,c and 3 . The sequences of the dierent primers were as follows: on the neo cassette: NeoI: 5'-GCTATTCGGCTATGACTGGG-3'; Neo2: 5'-GAAGGC-GATAGAAGGGCATG-3'; on the c-myc gene: 126: GAAC-GAGCTGAAGCGCA-3'; 199: 5'-GGAAGTTTGAGGAA-GAGG-3'. Ampli®cations were carried out for 35 cycles of 30 s at 948C, 1 min at 508C and 30 s to 2 min at 728C in a Crocodile Thermal Cycler (Appligene).
RNA extraction and S1 mapping assay
Total RNA was extracted from ES cells and dierent tissues of transgenic mice by the LiCl procedure (Auray and Rougeon, 1980) or using Trizol reagent (Gibco-BRL). For a given adult or embryonic tissue, extraction was performed from a pool of 2 ± 4 dierent embryos or mice of the same genotype to minimize individual variability. The 70% partial hepatectomy (Makino et al., 1984; Morello et al., 1990a) and the S1 mapping analysis have been previously described Oncogene Targeted c-myc 3' UTR modifications F Langa et al (Morello et al., 1986) . The following single-stranded radiolabeled probes were used: Hu (diagram Figure 2a) corresponded to a 478-bp-long PvuII-HindIII fragment, including part of the murine c-myc exon 3 (grey box), human myc sequences (hatched horizontal bars) and a loxP site (arrow) subcloned into M13mp18 vector. The length of the fragment protected from S1 nuclease digestion by hybridization to Myc* 3'SV mRNA was 458 nt; Mu (diagram Figure 2a ) corresponded to a 500-bp-long PvuII-HindIII fragment, including 367 bp of the murine c-myc exon 3 coding sequence (grey box) and part of the c-myc 3' UTR (black box), which was subcloned into M13mp18 vector. The hybridization temperature was 458C. The length of the fragment protected from S1 nuclease digestion by hybridization to c-myc wildtype mRNA was 500 nt. When the probe was uniformly radiolabeled, a 367-nt-long fragment corresponding to protection with Myc* 3'SV mRNA was also observed (diagram Figure 4a) . A probe hybridizing with neo transcripts initiated either at the c-myc promoters (readthrough) or polII promoter was constructed by subcloning a hybrid polII-neo 421-bp-long fragment into M13mp18 vector: After polymerization and EcoRI digestion, the length of the undigested probe was 450 nt, that of fragment protected by c-mycneo hybrid transcripts was 421 nt, while that protected by polII initiated neo transcripts was % 290 nt (diagram Figure 6a) . The hybridization temperature was 588C. The b2 m probe used as an internal control has been previously described (Morello et al., 1985) . The quanti®cation was performed using a Phosphorimager (FUJIX BAS 1000) and the values given in curves and histograms of Figures 2, 4 and 5 correspond to the wt or modi®ed gene (mg) signals divided by the b2 m signal found in the same RNA extract multiplied by 10 (106(wt/b2 m) or 106(mg/b2 m)).
Real-time quantitative RT ± PCR
RNAs were reverse transcribed in a ®nal volume of 20 ml containing 1X RT buer (500 mM each dNTP, 3 mM MgCl 2 , 75 mM KCl, 50 mM Tris-HCl pH 8.3), 10 units of RNasinTM Ribonuclease inhibitor (Promega, Madison, WI, USA), 10 mM dithiothreitol, 50 units of Superscript II RNase H-reverse transcriptase (Gibco-BRL, Gaithersburg, MD, USA), 1.5 mM random hexamers (Pharmacia, Uppsala, Sweden) and 1 mg of total RNA. The samples were incubated at 208C for 10 min and 428C for 30 min, and reverse transcriptase was inactivated by heating at 998C for 5 min and cooling at 58C for 5 min.
PCR was performed using the SYBR1 Green PCR Core Reagents kit and an ABI Prism 7700 sequence Detection System (Perkin Elmer Applied Biosystems) and two couples of primers (MYC TOU 1 ± 3 and 1 ± 4) to analyse modi®ed cmyc transcripts and two couples of primers to analyse TBP (TATA Box Binding Protein) and P0 (acidic ribosomal phosphoprotein P0) contents, which are used as internal references to normalise the dierent samples. Their sequences are: RPLPO U: GGC GAC CTG GAA GTC CAA CT, MRPLPO L: CAT CAG CAC CAC GGC CTT C, TBP U: TGC ACA GGA GCC AAG AGT GAA, TPB L: CAC ATC ACA GCT CCC CAC CA, MYCTOU 1: CAG CAT ACA TCC TGT CCG TC, MYCTOU 3: CCA GAG TTC CGT AGC TGT TCA, MYCTOU 4: CTC GAA TTC AGT TTA TGC ACC A. The thermal cycling conditions comprised an initial denaturation step at 958C for 10 min and 50 cycles at 958C for 15 s and 658C for 1 min. Experiments were carried out with duplicate (MYCTOU 1 ± 3 and 1 ± 4) or triplicate (P0 and TBP) samples for each data point. Results shown in Table 1 and 2 were determined according to (Bieche et al., 2000) . Brie¯y, the RNA sample from +/myc* 3'SV thymus which contains the smallest amount of c-myc mRNA was taken as the calibrator (cal) and arbitrarily expressed as 100. 
